logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

KKR to acquire Immedica Pharma, a Stockholm-based pharmaceutical company focused on rare diseases

Apr 23, 2024•over 1 year ago

Acquiring Company

KKR

Acquired Company

Immedica Pharma AB

HaryanaSwedenRenewables & EnvironmentPharmaceuticalBiotechnologyHealth Care

Description

KKR, a leading global investment firm, has agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. KKR, along with existing owner Impilo, will work together to support Immedica’s continued growth, including the launch of the recently approved ultra-orphan drug Loargys, additional pipeline assets, and an expansion into the U.S. market.

Company Information

Company

KKR

Location

Haryana, India

About

KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of The Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed